?
当前位置:澳门黄金赌城 > 小柯机器人 >详情
科学家利用人类组织筛选新技术发现大脑尺寸调控基因
作者:小柯机器人 发布时间:2020/10/30 14:49:52

奥地利科学院Jürgen A. Knoblich研究团队利用人类组织筛选新技术鉴定出一个ER分泌调控因子参与大脑尺寸决定。相关论文于2020年10月29日在线发表在《科学》杂志上。

研究人员报道了异质组织中细胞分辨率的CRISPR-LIneage追踪(CRISPR-LICHT),可在人脑类器官组织中进行并行功能丧失(LOF)研究。研究人员使用CRISPR-LICHT测试了173个小头畸形候选基因,并揭示了25个参与已知和未知的小头畸形相关途径。
 
研究人员表征了IER3IP1(Immediate Early Response 3 Interacting Protein 1)调节的未折叠的蛋白应答(UPR)和细胞外基质(ECM)蛋白质分泌对于组织完整性至关重要,其失调会导致小头畸形。这一人体组织筛选技术可鉴定涉及大脑大小控制的小头畸形基因和机制。
 
研究人员介绍,LOF筛选提供了一种强大的方法来鉴别生物过程中的调节因子。人类基因的LOF筛选目前仅限于二维(2D)细胞培养,这阻碍了对需要组织背景的基因功能进行测试。 
 
附:英文原文

Title: A human tissue screen identifies a regulator of ER secretion as a brain size determinant

Author: Christopher Esk, Dominik Lindenhofer, Simon Haendeler, Roelof A. Wester, Florian Pflug, Benoit Schroeder, Joshua A. Bagley, Ulrich Elling, Johannes Zuber, Arndt von Haeseler, Jürgen A. Knoblich

Issue&Volume: 2020/10/29

Abstract: Loss-of-function (LOF) screens provide a powerful approach to identify regulators in biological processes. Pioneered in laboratory animals, LOF screens of human genes are currently restricted to two-dimensional (2D) cell culture hindering testing of gene functions requiring tissue context. Here we present CRISPR-LIneage tracing at Cellular resolution in Heterogenous Tissue (CRISPR-LICHT), enabling parallel LOF studies in human cerebral organoid tissue. We used CRISPR-LICHT to test 173 microcephaly candidate genes revealing 25 to be involved in known and uncharacterized microcephaly-associated pathways. We characterized Immediate Early Response 3 Interacting Protein 1 (IER3IP1) regulating the unfolded protein response (UPR) and extracellular matrix (ECM) protein secretion crucial for tissue integrity, with dysregulation resulting in microcephaly. Our human tissue screening technology identifies microcephaly genes and mechanisms involved in brain size control.

DOI: 10.1126/science.abb5390

Source: https://science.sciencemag.org/content/early/2020/10/28/science.abb5390

期刊信息
Science:《科学》,创刊于1880年。隶属于美国科学促进会,最新IF:41.037
?